ArticlePloS one2026

Impact of MED12 mutation and CDK8 activity on uterine leiomyoma growth and response to gonadotropin-releasing hormone agonist treatment.

Saki Tanioka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.